Oral Vaccines Against Cholera

被引:49
作者
Shin, Sunheang [1 ]
Desai, Sachin N. [1 ]
Sah, Binod K. [1 ]
Clemens, John D. [1 ]
机构
[1] Int Vaccine Inst, Seoul 151919, South Korea
关键词
VIBRIO-CHOLERAE; WHOLE-CELL; FIELD TRIAL; COST-EFFECTIVENESS; ENDEMIC AREA; PROTECTIVE EFFICACY; MASS VACCINATION; CROSS-PROTECTION; CONTROL PROGRAMS; CVD; 103-HGR;
D O I
10.1093/cid/cir141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global burden has returned cholera to the forefront of global public health discussions. Improved water and sanitation should continue to be the mainstays of cholera-prevention efforts, but major improvements are a far-off goal for much of the cholera-affected developing world. The advent of safe and effective, new-generation oral vaccines against cholera has created renewed interest in the use of vaccines as a tool to control cholera.
引用
收藏
页码:1343 / 1349
页数:7
相关论文
共 53 条
  • [31] Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings - A cost-effectiveness analysis
    Naficy, A
    Rao, MR
    Paquet, C
    Antona, D
    Sorkin, A
    Clemens, JD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (07): : 521 - 525
  • [32] Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants
    Qadri, Firdausi
    Chowdhury, Mohiul I.
    Faruque, Shah M.
    Salam, Mohammed A.
    Ahmed, Tanvir
    Begum, Yasmin A.
    Saha, Amit
    Al Tarique, Abdullah
    Seidlein, Lorenz V.
    Park, Eunsik
    Killeen, Kevin P.
    Mekalanos, John J.
    Clemens, John D.
    Sack, David A.
    [J]. VACCINE, 2007, 25 (02) : 231 - 238
  • [33] Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
    Richie, E
    Punjabi, NH
    Sidharta, Y
    Peetosutan, K
    Sukandar, M
    Wasserman, SS
    Lesmana, M
    Wangsasaputra, F
    Pandam, S
    Levine, MM
    O'Hanley, P
    Cryz, SJ
    Simanjuntak, CH
    [J]. VACCINE, 2000, 18 (22) : 2399 - 2410
  • [34] Cholera
    Sack, DA
    Sack, RB
    Nair, GB
    Siddique, AK
    [J]. LANCET, 2004, 363 (9404) : 223 - 233
  • [35] Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea
    Sánchez, J
    Holmgren, J
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (04) : 388 - 398
  • [36] PROTECTIVE EFFICACY OF ORAL WHOLE-CELL RECOMBINANT-B-SUBUNIT CHOLERA VACCINE IN PERUVIAN MILITARY RECRUITS
    SANCHEZ, JL
    VASQUEZ, B
    BEGUE, RE
    MEZA, R
    CASTELLARES, G
    CABEZAS, C
    WATTS, DM
    SVENNERHOLM, AM
    SADOFF, JC
    TAYLOR, DN
    [J]. LANCET, 1994, 344 (8932) : 1273 - 1276
  • [37] El Tor cholera with severe disease: a new threat to Asia and beyond
    Siddique, A. K.
    Nair, G. B.
    Alam, M.
    Sack, D. A.
    Huq, A.
    Nizam, A.
    Longini, I. M., Jr.
    Qadri, F.
    Faruque, S. M.
    Colwell, R. R.
    Ahmed, S.
    Iqbal, A.
    Bhuiyan, N. A.
    Sack, R. B.
    [J]. EPIDEMIOLOGY AND INFECTION, 2010, 138 (03) : 347 - 352
  • [38] WHY TREATMENT CENTERS FAILED TO PREVENT CHOLERA DEATHS AMONG RWANDAN REFUGEES IN GOMA, ZAIRE
    SIDDIQUE, AK
    SALAM, A
    ISLAM, MS
    AKRAM, K
    MAJUMDAR, RN
    ZAMAN, K
    FRONCZAK, N
    LASTON, S
    [J]. LANCET, 1995, 345 (8946) : 359 - 361
  • [39] Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
    Sur, Dipika
    Lopez, Anna Lena
    Kanungo, Suman
    Paisley, Allison
    Manna, Byomkesh
    Ali, Mohammad
    Niyogi, Swapan K.
    Park, Jin Kyung
    Sarkar, Banawarilal
    Puri, Mahesh K.
    Kim, Deok Ryun
    Deen, Jacqueline L.
    Holmgren, Jan
    Carbis, Rodney
    Rao, Raman
    Van, Nguyen Thu
    Donner, Allan
    Ganguly, Nirmal K.
    Nair, G. Balakrish
    Battacharya, Sujit K.
    Clemens, John D.
    [J]. LANCET, 2009, 374 (9702) : 1694 - 1702
  • [40] ONSET AND DURATION OF PROTECTIVE IMMUNITY IN CHALLENGED VOLUNTEERS AFTER VACCINATION WITH LIVE ORAL CHOLERA VACCINE CVD 103-HGR
    TACKET, CO
    LOSONSKY, G
    NATARO, JP
    CRYZ, SJ
    EDELMAN, R
    KAPER, JB
    LEVINE, MM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (04) : 837 - 841